Sign In
Buy ADC
$76.32
-0.590 (-0.767%)
At Close: Aug 04, 2026
3 Big Dividend Laggards That Could Still Crush The Market In 2025
12:00pm, Thursday, 30'th Jan 2025
There are numerous high-quality, high-yielding stocks that trade at compelling bargains. I share three that have been lagging the S&P 500 so far this year that I think could turn it around and end up
ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
07:15am, Thursday, 30'th Jan 2025
LAUSANNE, Switzerland , Jan. 30, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced th
What I Wish I Knew Before Investing In Dividend Stocks
07:05am, Friday, 24'th Jan 2025
What I Wish I Knew Before Investing In Dividend Stocks
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC)
11:15pm, Wednesday, 22'nd Jan 2025
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ZL-131
The Ultimate Dividend Stock to Buy With $200 Right Now
07:10am, Wednesday, 22'nd Jan 2025
The ultimate dividend stock should offer a high yield first and foremost, plus growth and a stable business. It should be a stock that you can count on through thick and thin, and that can rise to sup
2 Of My Favorite Net Lease REITs Might Surprise You
08:00am, Sunday, 19'th Jan 2025
The net lease sector, with a market cap of ~$100B, has significant growth potential in diverse sub-categories like health & fitness, casinos, and data centers. Essential Properties and Agree Realty sh
7 Stocks I'm Buying Amid This Goldilocks (For Now) Economy
08:05am, Saturday, 18'th Jan 2025
There is an often overlooked difference between income investing and dividend growth investing. The two are not the same. Timely charts showing that inflation is even more subdued than the official CP
Agree Realty: Why I Bought More Of The Commons And Preferreds
09:02am, Friday, 17'th Jan 2025
I'm still buying Agree Realty's commons despite the REIT selloff, driven by the significant rise in long-term Treasury yields. ADC's strong financials include 12.8% revenue growth, 99.6% leased proper
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
07:00pm, Wednesday, 15'th Jan 2025
SAN FRANCISCO and SUZHOU, China , Jan. 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercial
Agree Realty Declares Monthly Common and Preferred Dividends
04:05pm, Tuesday, 14'th Jan 2025
ROYAL OAK, Mich. , Jan. 14, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a monthl
Agree Realty CEO Joey Agree on retail trends
02:17pm, Tuesday, 14'th Jan 2025
Joey Agree, president and CEO at Agree Realty, joins CNBC's The Exchange to discuss the rise in risks for commercial properties, recent retail trends, and more.
What I Wish I Knew Before Investing In Dividend Stocks
01:09pm, Tuesday, 14'th Jan 2025
Dividend investing has been very rewarding for me. However, I have learned a lot of lessons the hard way. I share some of the most important lessons I have learned in this article.
2 REITs That Make Sense To Own In 2025 And Beyond
07:45am, Tuesday, 14'th Jan 2025
Despite high-interest rates, REITs like Agree Realty and Realty Income offer attractive valuations and strong fundamentals, making them ideal for passive income investors. ADC boasts a 12% CAGR since
Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones
07:30am, Monday, 13'th Jan 2025
-- Initiated dosing in Phase 1 clinical trial cohort evaluating Claudin 18.2 ADC EO-3021 in combination with ramucirumab or dostarlimab in patients with advanced gastric/gastroesophageal junction (GE
Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs
08:04pm, Sunday, 12'th Jan 2025
NEW HAVEN, Conn. and UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Biohaven Ltd. (NYSE: BHVN) and Merus N.V. (Nasdaq:MRUS), today announced a research collaboration
